DactinomycinGestational Trophoblastic DiseaseWilms TumorRhabdomyosarcomaLeukocyte DisordersVincristineDoxorubicinTrophoblastic NeoplasmsCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsPulse Therapy, DrugEtoposideIfosfamideSarcoma, EwingBleomycinCombined Modality TherapyMethotrexateKidney NeoplasmsNeoplasms, Germ Cell and EmbryonalDrug Administration ScheduleDisease-Free SurvivalBone NeoplasmsTreatment OutcomeLomustineVinca AlkaloidsAntineoplastic Agents, PhytogenicNeoplasm StagingNeoplasm Recurrence, LocalSurvival RateVinblastineP-GlycoproteinDrug ResistanceAntibodies, Monoclonal, Murine-DerivedLeukemia P388Lymphoma, Non-HodgkinAsparaginaseAntineoplastic AgentsDaunorubicinDrug Resistance, MultiplePrednisoloneLymphoma, Large B-Cell, DiffuseRemission InductionCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseMelphalanOligodendrogliomaDexamethasoneVerapamilCarcinoma, Small CellDacarbazineDrug Resistance, NeoplasmCatharanthusSurvival AnalysisVindesineLeukemia, LymphoidCisplatinTeniposideColchicineSemustinePodophyllotoxinChlorambucilMitoxantroneLeukemia L1210Multiple MyelomaKB CellsTumor Cells, CulturedAntibiotics, AntineoplasticMultidrug Resistance-Associated ProteinsNimustineCarmustineLymphoma, FollicularDrug Screening Assays, AntitumorDose-Response Relationship, DrugDrug SynergismBrain NeoplasmsPrognosisPeripheral Nervous System DiseasesLymphoma, B-CellLymphomaLiposomesCell SurvivalMedulloblastomaAntimitotic AgentsPaclitaxelTime Factors6-MercaptopurineMesnaAstrocytomaLung NeoplasmsMicrotubulesNeuroblastomaTubulinLeukotriene C4Mitolactol